ID
24992
Description
A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00466440
Link
https://clinicaltrials.gov/show/NCT00466440
Keywords
Versions (1)
- 8/23/17 8/23/17 -
Uploaded on
August 23, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00466440
Eligibility Prostate Cancer NCT00466440
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Able to swallow Pills Lacking
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2712086
- UMLS CUI [1,2]
- C0994475
- UMLS CUI [1,3]
- C0332268
Description
Illness Serious | Exception Prostate carcinoma
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0221423
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0600139
Description
Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0013230
Description
Heart condition Serious
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3842523
- UMLS CUI [1,2]
- C0205404
Description
cancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0920425
Similar models
Eligibility Prostate Cancer NCT00466440
- StudyEvent: Eligibility
C1706276 (UMLS CUI [1,2])
C0031834 (UMLS CUI [1,3])
C0028900 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1999232 (UMLS CUI [2,3])
C0332197 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C0994475 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0205404 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])